Neogen Chemicals Ltd Q4 FY2023 Concall Summary

Source transcript PDF: https://assets.stockscans.in/docs/y5vai2qbqh62amkotq1ojbks.pdf

Key Takeaways


Battery Chemicals: The MUIS Licence & Electrolyte Roadmap

Dr. Harin Kanani: "MUIS, a global leader in electrolyte manufacturing, has issued its first ever licence to anyone in the world, and they have chosen Neogen Chemicals."

BuLi Chemicals Acquisition: Strategy & Contribution

Dr. Harin Kanani: "We also hope that the significant portion of this is consumed in house by our Dahej unit for the lithiation reaction and that will allow us to increase the contribution of either CSM or advanced intermediates and basically be the stepping stone on which or the foundation on which we can plan our future growth."

Margins: Lithium Pass-Through & Gross Margin Reset

Dr. Harin Kanani: "My guidance would be gross margin of 42%, +/-2% that we should look at in the near term, till we have certainty on gross margins better than that. We will let you know."

Organic Business: Capacity, Demand & Competitive Pressure


Lithium Price Dynamics & Competitive Positioning

Dr. Harin Kanani: "We should be somewhere around 10% or so costlier in worst-case scenario as compared to the Chinese at a comparable volumes and level. We are basically banking on that and we are also hoping that there is enough interest for a non-chinese source from a de-risking point of view to offset this 10% higher cost."

Balance Sheet & Working Capital


Guidance & Commitments

CommitmentSpecificsTimeline
Organic reactor capacityAdditional 29 m³ to be addedBy September 2023
Electrolyte salt & additives capacity400 MTPA new capacity commissionedJune or July 2023
1,000 MT electrolyte plantReady at DahejBy September 2023
FY24 revenue (stable lithium)₹800-825 crore (base ~₹750 crore + BuLi ₹50-75 crore)FY24
FY24 revenue (elevated lithium)₹850-875 croreFY24
FY24 EBITDA growth25-30% over FY23 EBITDAFY24
FY25 revenue₹900-1,050 crore, depending on lithium pricesFY25
Gross margin42% +/-2%Near term, until certainty improves
Inventory days~120 days on net salesBy FY24
Tax rateStart at 22-25%, move to 20-22%Over next two financial years
Electrolyte CAPEX plan for 30,000 MTPhasing plan to be sharedWithin two quarters
Electrolyte plant construction (post-CAPEX clarity)15-18 months to build and commissionStarting after CAPEX plan finalised
Peak organic revenue₹175-180 crore per quarterSometime in FY25

Key Metrics

MetricQ4 FY23
Revenue₹203.9 cr, +30% YoY
Organic chemicals revenue₹138 cr, +39% YoY
Inorganic chemicals revenue₹66 cr, +14% YoY
Domestic / export mix55% / 45%
EBITDA₹32.6 cr, +22% YoY
PAT₹14.3 cr
Gross margin~40%, down from 43–44% in Q1–Q3 FY23, driven by peak lithium prices in Dec–Jan inventory
FY24 revenue guidance₹800–825 cr on stable lithium prices, including BuLi Chem; ₹850–875 cr if lithium prices move up significantly
FY24 EBITDA growth guidance25–30% increase over FY23 EBITDA
FY25 revenue guidance₹900–1,050 cr, depending on lithium prices, based on committed CAPEX for regular business and BuLi Chem
Net debt₹265 cr (including current maturities of long-term debt)
New customers added in FY2382, contributing 7% to revenue
Total customer count~1,550
Products in portfolio245; 25 new products in R&D with future demand potential of ~₹2,000 cr
Electrolyte plant capacity timeline1,000 MT at Dahej expected ready by September 2023
Specialty electrolyte salt capacity timeline400 MTPA to be commissioned by June or July 2023